PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene

Haorui’s established footprint brings HiFi sequencing to new customers including hospital labs and regional blood centersMENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized leader in blood typing genomics, as an official distributor in China. The distribution arrangement is designed to expand access to PacBio’s HiFi long-read sequencing techn ...